PATENT CLAIM ANALYSIS

Application Number: 16156304
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["546", "141000"]

Abstract:
This invention relates to compounds of general formula (I) in which R 1 , R 2 , R 3 , R 4 , L, X and Z are as defined herein, and the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.

Claim (Index 20):
A method for the treatment of abnormal cell growth in a subject, comprising administering to the subject a therapeutically effective amount of a compound of  claim 13 , or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.58696
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14132567', '15585880', '14740439', '15921097', '14527328']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7808994752549898
- 35 USC 102 Novelty (BERT): 0.550296548769246
- Combined Prediction Score: 0.7578391826064155
- Mean Citation Score: 376.301718
- Max Citation Score: 420.27927
- Similarity Product: 306.4671449967635

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test